Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma

Abstract

Mutations in LKB1/STK11, a gene mapping to chromosome 19p13.3 and encoding a widely expressed serine/threonine kinase, were recently identified as the cause of Peutz-Jeghers syndrome. Despite the hamartomatous polyps and increased cancer risk associated with this syndrome, somatic alterations in LKB1/STK11 have not been identified in human tumours. Prompted by another feature of the syndrome, lentigines of the lips and oral mucosa, we evaluated the status of LKB1/STK11 expression, deletion, and mutation in cell lines and tumour samples from 35 patients with sporadic malignant melanoma. Two somatic mutations were identified, a nonsense mutation (Glu170Stop) causing exon skipping and intron retention, and a missense mutation (Asp194Tyr) affecting an invariant residue in the catalytic subunit of LKB1/STK11. Our data suggest that LKB1/STK11 may contribute to tumorigenesis in a small fraction of malignant melanomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abrams ES and Stanton VP. . 1992 Methods Enzymol. 212: 71–104.

  • Albino AP. . 1995 Curr. Opin. Oncol. 7: 162–169.

  • Avizienyte E, Roth S, Loukola A, Hemminki A, Lothe RA, Stenwig AE, FossÃ¥ SD, Salovaara R and Aaltonen LA. . 1998 Cancer Res. 58: 2087–2090.

  • Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J. . 1996 Cancer Res. 56: 5475–5483.

  • Bignell GR, Barfoot R, Seal S, Collins N, Warren W and Stratton MR. . 1998 Cancer Res. 58: 1384–1386.

  • Braitman M. . 1979 Cutis 23: 617–623.

  • Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG and Hayward NK. . 1997 Cancer Res. 57: 4868–4875.

  • Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, Krush AJ, Yardley JH and Luk GD. . 1987 N. Engl. J. Med. 316: 1511–1514.

  • Gibbs CS, Knighton DR, Sowadski JM, Taylor SS and Zoller MJ. . 1992 J. Biol. Chem. 267: 4806–4814.

  • Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J. . 1997 Cancer Res. 57: 3660–3663.

  • Hanks SK and Quinn AM. . 1991 Methods Enzymol. 200: 38–62.

  • Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H and Rees JL. . 1996 Cancer Res. 56: 589–593.

  • Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A and Aaltonen LA. . 1998 Nature 391: 184–187.

  • Hoffmeyer S, Nürnberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D and Krone W. . 1998 Am. J. Hum. Genet. 62: 269–277.

  • Howe JR, Roth S, Ringold JC, Summers RW, Järvinen HJ, Sistonen P, Tomlinson IM, Houlston RS, Bevan S, Mitros FA, Stone EM and Aaltonen LA. . 1998 Science 280: 1086–1088.

  • Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W and Zimmer M. . 1998 Nature Genet. 18: 38–43.

  • Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnik MH. . 1994 Science 264: 436–440.

  • Koh HK. . 1991 N. Engl. J. Med. 325: 171–182.

  • Li J, Yen C, Liaw D, Podyspanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. . 1997 Science 275: 1943–1947.

  • Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R. . 1997 Nature Genet. 16: 64–67.

  • Parmiter AH, Balaban G, Herlyn M, Clark Jr WH and Nowell PC. . 1986 Cancer Res. 46: 1526–1529.

  • Ray ME, Wistow G, Su YA, Meltzer PS and Trent JM. . 1997 Proc. Natl. Acad. Sci. USA 94: 3229–3234.

  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV. . 1997 Nature Genet. 15: 356–362.

  • Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A and Steck PA. . 1997 Cancer Res. 57: 5221–5225.

  • Tsao H, Zhang X, Benoit E and Haluska FG. . 1998 Oncogene 16: 3397–3402.

  • Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID and Fountain JW. . 1998 Genes Chromosom. Cancer 22: 157–163.

  • Welch DR and Goldberg SF. . 1997 Pathobiology 65: 311–330.

  • Wong SS and Rajakulendran S. . 1996 Br. J. Dermatol. 135: 439–442.

Download references

Acknowledgements

This work was supported by grants from the Danish Cancer Society, the Danish Medical Research Council, the Novo Nordisk Foundation, the Astrid Thaysen Foundation, and the Kaarsen Foundation.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guldberg, P., Straten, P., Ahrenkiel, V. et al. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 18, 1777–1780 (1999). https://doi.org/10.1038/sj.onc.1202486

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202486

Keywords

This article is cited by

Search

Quick links